Cargando…
Solubility Enhancement of Budesonide and Statistical Optimization of Coating Variables for Targeted Drug Delivery
The purpose of the research was to present Budesonide (BUD) as a novel formulation showing improved aqueous solubility, which may decrease variability in C (max) and T (max) found in inflammatory bowel disease (IBD) patients, and drug targeting to colon. To improve aqueous solubility, solid disper...
Autores principales: | Bhatt, Himanshu, Naik, Bhargavi, Dharamsi, Abhay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590827/ https://www.ncbi.nlm.nih.gov/pubmed/26556190 http://dx.doi.org/10.1155/2014/262194 |
Ejemplares similares
-
Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery
por: Raval, Mihir K, et al.
Publicado: (2013) -
Solubility of aceclofenac in polyamidoamine dendrimer solutions
por: Patel, Jaydeep, et al.
Publicado: (2011) -
Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2012) -
Solubility Optimization of Loxoprofen as a Nonsteroidal Anti-Inflammatory Drug: Statistical Modeling and Optimization
por: Alqarni, Mohammed, et al.
Publicado: (2022) -
Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution
por: Dash, Rajendra Narayan, et al.
Publicado: (2015)